Business
Kneat Announces Graduation to the Toronto Stock Exchange
Kneat Announces Graduation to the Toronto Stock Exchange Canada NewsWire ...
About this update from Kneat.com, Inc.
[{"type":"text","content":"\n \n \n \n Kneat Announces Graduation to the Toronto Stock Exchange\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n LIMERICK,\n \n Ireland\n \n ,\n \n Nov. 15, 2021\n \n /CNW/ -\n \n kneat.com, inc.\n \n (TSX: KSI)\n \n (\"Kneat\n \n or\n \n \"the Company\")\n \n a leader in digitizing and automating validation processes, is pleased to announce that, as of market open today, its common shares will begin trading on the Toronto Stock Exchange (TSX) under the symbol \"KSI\".  This follows the Company's\n \n previously announced\n \n conditional approval to uplist (the \"Uplisting\") from the TSX Venture Exchange (TSXV).\n \n \n \n \n \n \n \n \n \n \"Kneat has demonstrated tremendous growth since its initial listing on the TSXV. With our increased scale and growing total addressable market, we believe it's the ideal time to graduate to the TSX. This listing will not only increase global visibility for Kneat and our industry leading technology, but also provide us with access to a broader range of investors seeking to invest in one of the world's leading life sciences software companies,\"\n \n said\n \n Eddie Ryan\n \n , Chief Executive Officer of Kneat.\n \n \n \n Effective at market open on\n \n November 15\n \n \n th\n \n , 2021, Kneat's common shares will concurrently be delisted from the TSXV.\n \n \n \n About Kneat\n \n \n \n Kneat, a Canadian company with operational headquarters in Limerick,\n \n Ireland\n \n , develops and markets the next generation Kneat Gx SaaS platform. Multiple business work processes can be configured on the platform from equipment to computer system validation, through to quality document management. Kneat's software allows users to author, review, approve, execute testing online, manage any exceptions, and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects, and processes globally. Customer case studies are reporting productivity improvements in excess of...